In order to clarify the anti-SARS-CoV-2 potency of anti-androgen molecules, we investigated the role of apalutamide, another AR inhibitor recently approved for advanced PCa treatment, during SARS-CoV-2 infection of lung adenocarcinoma Calu-3 and primary human nasal epithelial cells. This evidence concerns the gene AR and posterior cortical atrophy.